SEC Form D filing

Strand Therapeutics Inc., 2026-03-17

An SEC Form D private-offering notice from Boston, MA, a $120,099,940 filer-stated offering target in Biotech. Filed 2026-03-17. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Strand Therapeutics Inc. site↗ Verified via SEC Form D

Clinical-stage biotech using synthetic biology to develop programmable mRNA immunotherapies for cancer and autoimmune disease.

Filed 2026-03-17Filed to raise $120,099,940First money in 2025-05-23Raised so far $108,099,927HQ (as filed) Boston, MASector Biotech web-verified against the company’s own siteStage (inferred) LateCall status Late filing
Source linked the Form D on EDGAR↗Website verified strandtx.com↗Named in the filing 7 executives & directors
Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source